Health Matters: Our Microbiome Is Key
Dr. Irah King describes the role our microbiome plays in our overall health on the MUHC Foundation’s Health Matters.
According to the WHO, respiratory disorders are leading causes of death world-wide (second only to heart attack & stroke). These include diseases such as obstructive lung diseases and pulmonary infections. As a result, our research is focused around four main pulmonary research themes. These include: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, and sleep-disordered breathing.
Above all, a multidisciplinary approach is used to study the basic mechanisms of a number of diseases. These include asthma, chronic obstructive pulmonary disease, pulmonary infections, cystic fibrosis, sleep apnea, respiratory muscle disorders, pulmonary fibrosis, lung injury, and rare respiratory diseases. Research at the Meakins also involves the study of human physiology and tissues in parallel with relevant animal and cell culture models. Furthermore, research is facilitated by the availability of a variety of core facilities for both clinical and fundamental studies.
Learn more about our research themes here.
Below you will see posts and news items related to our research themes.
Dr. Irah King describes the role our microbiome plays in our overall health on the MUHC Foundation’s Health Matters.
MUHC Foundation Health Matters interview with Benjamin Smith discusses lung diseases and the concept of resilient lungs
Dr. Kristof explains how the pediatric and adult hospitals worked together to save a patient with severe COVID-19.
Dr. Janaudis-Ferreira receives the CRHP’s 2021 Distinction Award in recognition of her contributions.
Dr. Dao Nguyen receives MI4 Seed Funding to develop rapid phenotypic antibiotic susceptibility testing
MUHC Foundation Health Matters podcast discusses the merger between the Montreal Chest Institute Foundation and the MUHC Foundation
March 24 was World TB Day 2021 and the McGill International TB Centre receives CIHR funds to continue its research.
Dr. Azuelos is dedicated to improving outcomes for ILD patients and their quality of life.
Dr. Ben Smith awarded catalyst grant to study a new paradigm for personalizing COPD prevention, prognosis, and pharmacotherapy
MUHC Foundation Health Matters interview with Basil Petrof about the historic Montreal Chest Institute